English
Back
Download
Log in to access Online Inquiry
Back to the Top

Update

$Savara (SVRA.US)$ Reuters· just
Savara Initiates Rolling Submission of a Biologics License Application (Bla) to the U.S. Food and Drug Administration (FDA) for Molbreevi* for the Potential Treatment of Autoimmune Pulmonary Alveolar Proteinosis (Apap)
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
2
+0
Translate
Report
2592 Views
Comment
Sign in to post a comment
    5121
    Followers
    24
    Following
    74K
    Visitors
    Follow